首页|甲泼尼龙与多索茶碱联合治疗老年性慢性阻塞性肺气肿的临床效果

甲泼尼龙与多索茶碱联合治疗老年性慢性阻塞性肺气肿的临床效果

扫码查看
目的 分析甲泼尼龙与多索茶碱联合治疗老年性慢性阻塞性肺气肿的临床效果。方法 114 例老年性慢性阻塞性肺气肿患者,通过信封抽签方法分为观察组和对比组,每组 57 例。对比组常规应用抗生素治疗,观察组应用甲泼尼龙与多索茶碱联合治疗。比较两组患者治疗前后的炎性因子[白介素-8(IL-8)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]水平、血气指标[动脉血氧饱和度(SaO2)、动脉血二氧化碳分压(PaCO2)、动脉血氧分压(PaO2)]水平、肺功能指标[第 1 秒用力呼气容积/用力肺活量(FEV1/FVC)、呼气流量峰值(PEF)、FEV1]水平以及临床效果、不良反应发生情况。结果 治疗后,两组IL-8、IL-6、TNF-α水平均明显下降,且观察组IL-8(20。65±3。38)pg/ml、IL-6(23。47±6。15)ng/L、TNF-α(123。41±17。64)pg/ml与对比组的(34。35±5。17)pg/ml、(42。55±7。11)ng/L、(155。75±20。47)pg/ml相比明显更低,体现统计学差异(P<0。05)。治疗后,两组SaO2、PaCO2、PaO2 水平均明显改善,且观察组SaO2(96。34±4。90)%、PaO2(79。45±5。64)mm Hg(1 mm Hg=0。133 kPa)均高于对比组的(89。22±3。87)%、(73。28±4。55)mm Hg,PaCO2(40。34±3。23)mm Hg低于对比组的(53。67±4。27)mm Hg,体现统计学差异(P<0。05)。治疗后,两组患者FEV1/FVC、PEF、FEV1 水平均明显提高,且观察组的FEV1/FVC(75。76±9。31)%、PEF(4。66±0。96)L/s、FEV1(4。42±0。82)L和对比组的(66。94±8。08)%、(3。70±0。74)L/s、(3。38±0。52)L比较明显更高,体现统计学差异(P<0。05)。观察组治疗总有效率 94。74%显著高于对比组的 82。46%,体现统计学差异(P<0。05)。两组患者不良反应发生率对比未体现明显差异(P>0。05)。结论 甲泼尼龙与多索茶碱联合治疗老年性慢性阻塞性肺气肿能帮助患者改善肺功能、血气指标,减少机体的炎症反应,进而促进整体治疗效果提升。
Clinical efficacy of methylprednisolone combined with doxofylline in the treatment of chronic obstructive pulmonary emphysema in the elderly
Objective To analyze the clinical efficacy of methylprednisolone combined with doxofylline in the treatment of chronic obstructive pulmonary emphysema in the elderly.Methods A total of 114 elderly patients with chronic obstructive pulmonary emphysema were divided into an observation group and a control group by envelope drawing method,with 57 cases in each group.The control group was treated with antibiotics,and the observation group was treated with methylprednisolone combined with doxofylline.Patients in both groups were compared in terms of inflammatory factors[interleukin-8(IL-8),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)],blood gas index[arterial oxygen saturation(SaO2),arterial partial pressure of carbon dioxide(PaCO2),arterial partial pressure of oxygen(PaO2)]and pulmonary function index[ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC),peak expiratory flow(PEF),FEV1]levels,clinical effects,and occurrence of adverse reactions.Results After treatment,the levels of IL-8,IL-6 and TNF-α decreased significantly in both groups;the observation group had IL-8 of(20.65±3.38)pg/ml,IL-6 of(23.47±6.15)ng/L and TNF-α of(123.41±17.64)pg/ml,which were significantly lower than(34.35±5.17)pg/ml,(42.55±7.11)ng/L and(155.75±20.47)pg/ml in the control group;there was a statistical difference(P<0.05).After treatment,the levels of SaO2,PaCO2 and PaO2 were significantly improved in both groups;the observation group had SaO2 of(96.34±4.90)%and PaO2 of(79.45±5.64)mm Hg(1 mm Hg=0.133 kPa),which were higher than(89.22±3.87)%and(73.28±4.55)mm Hg in the control group;the observation group had lower PaCO2 of(40.34±3.23)mm Hg than(53.67±4.27)mm Hg in the control group;there was a statistical difference(P<0.05).After treatment,the levels of FEV1/FVC,PEF and FEV1 were significantly increased in both groups;the observation group had FEV1/FVC of(75.76±9.31)%,PEF of(4.66±0.96)L/s and FEV1 of(4.42±0.82)L,which were significantly higher than(66.94±8.08)%,(3.70±0.74)L/s and(3.38±0.52)L in the control group;there was a significant difference(P<0.05).The total effective rate of the observation group was 94.74%,which was significantly higher than 82.46%of the control group,and there was a statistical difference(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of methylprednisolone and doxofylline in the treatment of elderly patients with chronic obstructive pulmonary emphysema can help patients improve lung function,blood gas indicators,reduce inflammation in the body,and promote overall treatment effectiveness.

Chronic obstructive pulmonary emphysemaOld ageMethylprednisoloneDoxofyllineInflammatory factors

张庆杰

展开 >

276400 沂水县人民医院

慢性阻塞性肺气肿 老年 甲泼尼龙 多索茶碱 炎性因子

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(9)